Search Within

Saad Zafar Usmani

  1. "Epidemiology and Biostatistics"
Formats
  1. Meeting Abstract (56)
  2. Journal Article (15)
  3. Research Letter (3)
  4. Correspondence (2)
Groups
  1. Epidemiology and Biostatistics (76)
  2. Department of Medicine (73)
  3. Hematologic Malignancies, Division of (73)
  4. Center for Hematologic Malignancies (71)
  5. Biostatistics Service (69)
  6. Myeloma (69)

More Groups

People
  1. Alexander Lesokhin (66)
  2. Urvi Shah (62)
  3. Kylee Maclachlan (59)
  4. Malin Hultcrantz (59)
  5. Sham Mailankody (59)
  6. Andriy Derkach (57)

More People

Years
  1. 2025 (3)
  2. 2024 (23)
  3. 2023 (30)
  4. 2022 (20)
Publications
  1. Clinical Lymphoma, Myeloma and Leukemia (25)
  2. Blood (23)
  3. Journal of Clinical Oncology (10)
  4. Blood Cancer Journal (6)
  5. Blood Advances (3)
  6. New England Journal of Medicine (2)

More Publications

Publishers
  1. American Society of Hematology (26)
  2. Elsevier Inc. (26)
  3. American Society of Clinical Oncology (10)
  4. Nature Publishing Group (7)
  5. Massachusetts Medical Society (2)
  6. American Association for Cancer Research (1)

More Publishers

Results (76)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Incidence and clinical impact of acute kidney injury: A comparison of CAR T-cell and bispecific antibody therapies
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Nemirovsky, D.; Derkach, A.; Costa, B.; Farzana, T.; Jurgens, E.; Firestone, R.; Nath, K.; Chung, D.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • CMV reactivation during treatment with bispecific antibodies for relapsed/refractory multiple myeloma
    Meeting Abstract

    Jurgens, E.; Shekarkhand, T.; Rueda, C.; Nemirovsky, D.; Derkach, A.; Firestone, R.; Miller, K.; Costa, B.; Rajeeve, S.; Lesokhin, A.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Phase I trial of MCARH109, a first-in-class G Protein Coupled Receptor Class C Group 5 Member D (GPRC5D)-targeted CAR T-cell therapy for relapsed or refractory multiple myeloma: Updated analysis
    Meeting Abstract

    Jurgens, E.; Firestone, R.; Chaudhari, J.; Hosszu, K.; Devlin, S.; Shah, U.; Landa, J.; McAvoy, D.; Lesokhin, A.; Korde, N.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Single cell whole genome measurement of genomic heterogeneity and clonal evolution in multiple myeloma
    Meeting Abstract

    McPherson, A.; Maclachlan, K.; Myers, M.; Satas, G.; Garcés, J. J.; Lee, H.; Bahlis, N. J.; Usmani, S.; Shah, S.; Maura, F.
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Maintenance therapy cessation for multiple myeloma patients with three-year sustained mrd negative remissions
    Meeting Abstract

    Korde, N.; Hassoun, H.; Landau, H.; Hamid, S.; Derkach, A.; Hultcrantz, M.; Mailankody, S.; Tan, C.; Shah, U.; Maclachlan, K.; more...
    Clinical Lymphoma, Myeloma and Leukemia (2024)

    Fulltext@MSK | Save
  • Artificial intelligence enabled interpretation of ECG images to predict hematopoietic cell transplantation toxicity
    Journal Article

    Shaffer, B. C.; Brown, S.; Chinapen, S.; Mangold, K. E.; Lahoud, O.; Lopez-Jimenez, F.; Schaffer, W.; Liu, J.; Giralt, S.; Devlin, S.; more...
    Blood Advances (2024)

    Fulltext@MSK | Save
  • Colesevelam for lenalidomide associated diarrhea in patients with multiple myeloma
    Research Letter

    Hultcrantz, M.; Hassoun, H.; Korde, N.; MacLachlan, K.; Mailankody, S.; Patel, D.; Shah, U. A.; Tan, C. R.; Chung, D. J.; Lahoud, O. B.; more...
    Blood Cancer Journal (2024)

    Fulltext@MSK | Save
  • Diagnosis disclosure patterns among patients with plasma cell disorders
    Meeting Abstract

    Malik, M.; Dalvi, A.; Derkach, A.; Aldana, A. M. S. S.; Martinez, J. A. H.; Merlo, G.; Ahlstrom, J. M.; Hydren, J. R.; Usmani, S. Z.; Chimonas, S.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Supplement use habits and perceptions in patients with plasma cell disorders
    Meeting Abstract

    Leyfman, Y.; Schach, E.; Derkach, A.; Castro, F.; Martínez, J. A. H.; Aldana, A. M. S. S.; Pérez, P. A. F.; Malik, M.; Ahlstrom, J. M.; Hydren, J. R.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Real-world schedule de-escalation of teclistamab in patients with relapsed/refractory multiple myeloma
    Meeting Abstract

    Tan, C. R. C.; Derkach, A.; Maclachlan, K.; Hultcrantz, M.; Hassoun, H.; Mailankody, S.; Shah, U. A.; Rajeeve, S.; Shah, G. L.; Scordo, M.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save